Clinical outcome after re-occlusion of initially successful remote endarterectomy of the superficial femoral artery

Journal of Cardiovascular Surgery

Volumn 48, Issue 3, 2007, Pages 309-314

  Smeets, Luuk ^a   Huijbregts, H J T A M ^b   Ho, G H ^c   De Vries, J P P M ^d   Moll, F L ^b  

^a TWENTEBORG HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c AMPHIA HOSPITAL   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Amputation; Endarterectomy; Gangrene; Gangrene amputation claudication; Intermittent claudication; Ischemia; Minimally invasive surgical procedures; Patient outcome assessment; Peripheral vascular disease; Popliteal artery; Superficial femoral artery; Vascular surgical procedures

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; WARFARIN;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; BELOW KNEE AMPUTATION; BLOOD CLOT LYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENDARTERECTOMY; FEMALE; FEMOROPOPLITEAL BYPASS; GANGRENE; HUMAN; INCIDENCE; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; OUTCOME ASSESSMENT; POSTOPERATIVE THROMBOSIS; RECANALIZATION; RECURRENT DISEASE; REOPERATION; SUPERFICIAL FEMORAL ARTERY OCCLUSION; SYMPTOM; THROMBECTOMY; TREATMENT INDICATION; VEIN BYPASS;

ADULT; AGED; AGED, 80 AND OVER; AMPUTATION; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS IMPLANTATION; ENDARTERECTOMY; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; GANGRENE; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; REOPERATION; SAPHENOUS VEIN; SEVERITY OF ILLNESS INDEX; THROMBECTOMY; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 34447506057     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Devalia K, Magee TR, Galland RB. Remote superficial femoral endarterectomy: Long-term results. Eur J Vasc Endovasc Surg 2006;31:262-5.
2. Martin JD, Hupp JA, Peeler MO, Warble PB. Remote endarterectomy: Lessons learned after more than 100 cases. J Vasc Surg 2006;43:320-6.
3. Schouten O, Hoedt MTC, Wittens CHA, Hop WCJ, van Sambeek MRHM, van Urk H; on behalf of the VASCAN study group. End-to-end versus end-to-side distal anastomosis in femoropopliteal bypasses; results of a randomized multicenter trial. Eur J Vasc Endovasc Surg 2005;29:457-62.
4. Berglund J, Björck M, Elfström J; on behalf of the SWEDVASC Femoro-popliteal Study Group. Long-term results of above knee femoro-popliteal bypass depend on indication for surgery and graft-material. Eur J Vasc Endovasc Surg 2005;29:412-18.
5. Smeets L, Ho GH, Tangelder MJD, Algra A, Lawson JA, Eikelboom BC, Moll FL; on behalf of the Dutch BOA Study Group. Outcome after occlusion of infrainguinal bypasses in the Dutch BOA study: comparison of amputation rate in venous and prosthetic grafts. Eur J Vasc Endovasc Surg 2005;30:604-9.
6. Devine C, McCollum C, on behalf of The North West Femoro-Popliteal Trial Participants. Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial. J Vasc Surg 2004;40:924-31.
7. Ballotta E, Renon L, Toffano M, Da Giau G. Prospective randomized study on bilateral above-knee femoropopliteal revascularization: Polytetrafluoroethylene graft versus reversed saphenous vein. J Vasc Surg 2003;38:1051-5.
8. Klinkert P, Schepers A, Burger DC, van Bockel JH, Breslau PJ. Vein versus polytetrafluorethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg 2003;37:149-55.
9. Jackson MR, Belott TP, Dickason T, Kaiser WJ, Modrall JG, Valentine RJ, Clagett GP. The consequences of a failed femoropopliteal bypass grafting: comparison of saphenous vein and PTFE grafts. J Vasc Surg 2000;32:498-505.
10. AbuRahma AF, Robinson PA, Holt SM. Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patiens with bilateral above knee femoropopliteal bypasses. Surgery 1999;126:594-601.
11. van der Heijden FH, Eikelboom BC, van Reedt Dortland RW, van der Graaf P. Superficial femoral artery and the outcome of failed reconstructions. J Vasc Surg 1993;8:271-9.
12. John TG, Stonebridge PA, Kelman J, Murie JA, Jenkins AMcL, Ruckley CV. Above-knee femoropopliteal bypass grafts and the consequence of graft failure. Ann Royal Coll Surg Engl 1993;75:257-60.
13. O'Riordain DS, Buckley DJ, O'Donnel JA. Polytetrafluoroethylene in above-knee arterial bypass surgery for critical ischemia. Am J Surg 1992;164:129-31.
14. Blankensteijn JD, Van Vroonhoven ThJMV. Consequences of failure of femoropopliteal grafts for claudication. Eur J Vasc Surg 1988;2:183-9.
15. Brewster DC, LaSalle AJ, Robinson JG, Strayhorn EC, Darling RC. Femoropopliteal graft failures. Arch Surg 1983;118:1043-7.
16. TASC Working group. D4 Treatment of critical limb ischaemia. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-S289.
17. Green RM, Abbot WM, Matsumoto T, Wheeler JR, Miller N, Veith FJ et al. Prosthetic above-knee femoropopliteal bypass grafting: Five-year results of a randomized trial. J Vasc Surg 2000;31:417-25.
18. Johnson WC, Lee K.K. A comparative evaluation of polytetrafluorethylene, umbilical vein and saphenous vein bypass grafts for femoral-popliteal above knee revascularization. A prospective randomized department of veterans affairs cooperative study. J Vasc Surg 2000;32:268-77.
19. Devine C, McCollum C, on behalf of The North West Femoro-Popliteal Trial Participants. Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial. J Vasc Surg 2004;40:924-31.
20. Klinkert P, Oost PN, Breslau PJ, Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of literature. Eur J Vasc Endovasc Surg 2004;27:357-62.
21. Smeets L, Ho GH, Hagenaars T, van den Berg JC, Teijink JAW, Moll FL. Remote endarterectomy: First choice in surgical treatment of long segmental SFA occlusive disease? Eur J Vasc Endovasc Surg 2003;25:583-9.
22. Breslau PJ, Jorning PJG, Dassen P. The natural history of intermittent claudication, a prospective study. Presented at 2nd International Vascular Symposium, London, United Kingdom, September 1986.
23. Gilliland EL, Llewellyn CD, Goss DE, Lewis JD. The morbidity and mortality of stable claudicants: results of five year follow up. Presented at the 2nd International Vascular symposium, London, United Kingdom, September 1986.
24. Klinkert P, Oost PN, Breslau PJ, Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of literature. Eur J Vasc Endovasc Surg 2004;27:357-62.
25. Knight JS, Smeets L, Morris GE, Moll FL. Multi centre study to assess the feasibility of a new covered stent and delivery system in combination with remote superficial femoral artery endarterec-